CHAO H ET AL: "Sustained expression of human factor VIII in mice using a parvovirus-based vector", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, & 55TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; NEW ORLEANS, LA, USA; DECEMBER 07 -10, 2013, vol. 95, no. 5, 1 March 2000 (2000-03-01), pages 1594-1599, XP002162031, ISSN: 0006-4971 (B1)

GNATENKO D V ET AL: "HUMAN FACTOR VIII CAN BE PACKAGED AND FUNCTIONALLY EXPRESSED IN AN ADENO-ASSOCIATED VIRUS BACKGROUND: APPLICABILITY TO HAEMOPHILIA A GENE THERAPY", BRITISH JOURNAL OF HAEMATOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 104, no. 1, 1 January 1999 (1999-01-01), pages 27-36, XP000982772, ISSN: 0007-1048, DOI: 10.1046/J.1365-2141.1999.01137.X (B1)

MCINTOSH J ET AL: "Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant", BLOOD, [Online] vol. 121, no. 17, 25 April 2013 (2013-04-25), pages 3335-3344, XP002727999, ISSN: 0006-4971, DOI: 10.1182/BLOOD-2012-10-462200 [retrieved on 2014-07-29] cited in the application (B1)

ZHIJIAN WU ET AL: "Optimization of Self-complementary AAV Vectors for Liver-directed Expression Results in Sustained Correction of Hemophilia B at Low Vector Dose", MOLECULAR THERAPY, vol. 16, no. 2, 1 February 2008 (2008-02-01), pages 280-289, XP055097643, ISSN: 1525-0016, DOI: 10.1038/sj.mt.6300355 (B1)

US-A1- 2007 042 462 (B1)

WO-A1-2011/005968 (B1)

R. SARKAR ET AL: "A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, vol. 1, no. 2, 1 February 2003 (2003-02-01), pages 220-226, XP055157373, ISSN: 1538-7933, DOI: 10.1046/j.1538-7836.2003.00096.x (B1)